Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?

Humans Onchocerciasis / drug therapy Ivermectin Mass Drug Administration Africa / epidemiology Neglected Diseases
MDA ivermectin mass drug administration modelling moxidectin onchocerciasis

Journal

Philosophical transactions of the Royal Society of London. Series B, Biological sciences
ISSN: 1471-2970
Titre abrégé: Philos Trans R Soc Lond B Biol Sci
Pays: England
ID NLM: 7503623

Informations de publication

Date de publication:
09 10 2023
Historique:
medline: 22 8 2023
pubmed: 21 8 2023
entrez: 20 8 2023
Statut: ppublish

Résumé

Epidemiological and modelling studies suggest that elimination of

Identifiants

DOI: 10.1098/rstb.2022.0277 PMID: 37598705 PMC: PMC10440165
pubmed: 37598705
doi: 10.1098/rstb.2022.0277
pmc: PMC10440165
doi:

Substances chimiques

moxidectin NGU5H31YO9
Ivermectin 70288-86-7

Banques de données

figshare
['10.6084/m9.figshare.c.6751749']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20220277

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom

Références

PLoS Negl Trop Dis. 2017 Jul 26;11(7):e0005816
pubmed: 28746337
Parasit Vectors. 2016 Nov 14;9(1):581
pubmed: 27842567
Parasit Vectors. 2015 Oct 22;8:552
pubmed: 26489937
Trop Med Infect Dis. 2019 Jul 15;4(3):
pubmed: 31311093
Parasit Vectors. 2015 Dec 30;8:667
pubmed: 26715524
Trop Med Infect Dis. 2019 Jun 13;4(2):
pubmed: 31200509
Trop Med Parasitol. 1993 Sep;44(3):155-8
pubmed: 8256088
Gates Open Res. 2019 Sep 26;3:1545
pubmed: 31723729
Ethiop J Health Sci. 2017 Mar;27(2):129-138
pubmed: 28579708
Lancet. 1997 Jul 5;350(9070):18-22
pubmed: 9217715
Adv Parasitol. 2016;94:247-341
pubmed: 27756456
Lancet. 2018 Oct 6;392(10154):1207-1216
pubmed: 29361335
Epidemics. 2017 Mar;18:4-15
pubmed: 28279455
Lancet Glob Health. 2020 Nov;8(11):e1418-e1426
pubmed: 33069302
Trans R Soc Trop Med Hyg. 1994 Sep-Oct;88(5):581-4
pubmed: 7992347
Parasit Vectors. 2014 Jul 22;7:325
pubmed: 25053266
PLoS Negl Trop Dis. 2013;7(2):e2084
pubmed: 23469307
Parasit Vectors. 2015 Mar 19;8:167
pubmed: 25889256
Expert Rev Anti Infect Ther. 2020 Nov;18(11):1067-1081
pubmed: 32715787
PLoS Negl Trop Dis. 2016 Aug 16;10(8):e0004905
pubmed: 27529622
Trends Parasitol. 2022 Jul;38(7):591-604
pubmed: 35379556
PLoS Negl Trop Dis. 2018 Mar 1;12(3):e0006312
pubmed: 29494606
Int Health. 2022 Sep 21;14(Suppl 2):ii43-ii54
pubmed: 36130252
PLoS Negl Trop Dis. 2015 May 14;9(5):e0003542
pubmed: 25974211
PLoS Negl Trop Dis. 2022 Apr 27;16(4):e0010079
pubmed: 35476631
PLoS Negl Trop Dis. 2022 Mar 25;16(3):e0010005
pubmed: 35333880
Infect Dis Poverty. 2016 Jun 27;5(1):66
pubmed: 27349645
PLoS Negl Trop Dis. 2014 Jun 26;8(6):e2953
pubmed: 24968000
Am J Trop Med Hyg. 2020 Sep;103(3):1135-1142
pubmed: 32588807
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16716-21
pubmed: 19805362
Parasitology. 2008 Nov;135(13):1571-81
pubmed: 18831801
Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):272-286
pubmed: 27693536
BMJ Glob Health. 2021 Jan;6(1):
pubmed: 33431378
Parasit Vectors. 2020 May 15;13(1):258
pubmed: 32414398
Lancet. 2002 Jul 20;360(9328):203-10
pubmed: 12133654
Clin Infect Dis. 2017 Nov 29;65(12):2026-2034
pubmed: 29020189
Clin Infect Dis. 2016 Jun 1;62(11):1338-1347
pubmed: 27001801
Trop Med Parasitol. 1989 Sep;40(3):367-74
pubmed: 2617046
Int J Parasitol. 2004 Aug;34(9):1069-74
pubmed: 15313133
PLoS Negl Trop Dis. 2013 Sep 19;7(9):e2452
pubmed: 24069497
Int Health. 2018 Mar 1;10(suppl_1):i79-i88
pubmed: 29471335
J Infect Dis. 1995 Jul;172(1):204-10
pubmed: 7797912
Trop Med Int Health. 1997 Sep;2(9):912-6
pubmed: 9315050
Lancet Infect Dis. 2008 May;8(5):310-22
pubmed: 18471776
PLoS Med. 2006 Sep;3(9):e371
pubmed: 17002504
PLoS Negl Trop Dis. 2016 Feb 29;10(2):e0004392
pubmed: 26926855
Am J Trop Med Hyg. 1992 Aug;47(2):156-69
pubmed: 1503185
Parasit Vectors. 2011 Jul 27;4:152
pubmed: 21794139
Int Health. 2018 Mar 1;10(suppl_1):i71-i78
pubmed: 29471334
PLoS Negl Trop Dis. 2019 Dec 5;13(12):e0007557
pubmed: 31805049
PLoS One. 2021 Dec 21;16(12):e0260722
pubmed: 34932602
Trends Parasitol. 2005 Feb;21(2):88-96
pubmed: 15664532
Trop Med Int Health. 2007 Feb;12(2):260-8
pubmed: 17300634
Parasit Vectors. 2019 May 20;12(1):246
pubmed: 31109348
Int Health. 2018 Mar 1;10(suppl_1):i40-i48
pubmed: 29471342
Am J Trop Med Hyg. 2016 Nov 2;95(5):1037-1040
pubmed: 27352878
PLoS Negl Trop Dis. 2018 Nov 14;12(11):e0006904
pubmed: 30427830
PLoS Negl Trop Dis. 2021 Feb 18;15(2):e0009064
pubmed: 33600426
N Engl J Med. 2017 Nov 23;377(21):2044-2052
pubmed: 29116890
Int J Parasitol Drugs Drug Resist. 2012 Apr 14;2:134-53
pubmed: 24533275
PLoS Negl Trop Dis. 2009 Jul 21;3(7):e497
pubmed: 19621091

Auteurs

Klodeta Kura (K)

London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, UK.
MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, UK.
ORCID: 0000-0002-0008-1440

Philip Milton (P)

London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, UK.
MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, UK.

Jonathan I D Hamley (JID)

London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, UK.
MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, UK.

Martin Walker (M)

London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, UK.
Department of Pathobiology and Population Sciences, Royal Veterinary College, Hatfield AL9 7TA, UK.

Didier K Bakajika (DK)

Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN), African Regional Office of the World Health Organization (WHO/AFRO/ESPEN), Brazzaville, Democratic Republic of Congo.

Eric M Kanza (EM)

Programme Nationale de Lutte contre les Maladies Tropicales Négligées à Chimiothérapie Préventive (PNLMTN-CTP), Ministère de la Santé Publique, Kinshasa, Democratic Republic of the Congo.

Nicholas O Opoku (NO)

Department of Epidemiology and Biostatistics, School of Public Health, University of Health and Allied Sciences, Hohoe, Ghana.

Hayford Howard (H)

Liberia Institute for Biomedical Research (LIBR), Monrovia, Liberia.

Maurice M Nigo (MM)

Institut Supérieur des Techniques Médicales de Nyankunde, Bunia, Democratic Republic of the Congo.

Sampson Asare (S)

GlycoScience Research, Brookings, SD 57006, USA.

George Olipoh (G)

Precious Minerals Marketing Company, National Assay Centre, Technical Department, Diamond House, Accra, GA-143-2548, Ghana.

Simon K Attah (SK)

Department of Medical Microbiology, University of Ghana Medical School, College of Health Sciences, Accra, Ghana.

Germain L Mambandu (GL)

Inspection Provinciale de la Santé de la Tshopo, Kisangani, Democratic Republic of the Congo.

Kambale Kasonia Kennedy (KK)

Department of Clinical Research, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

Kambale Kataliko (K)

Centre de Santé CECA 20 de Mabakanga, Beni, Nord Kivu, Democratic Republic of the Congo.

Mupenzi Mumbere (M)

Medicines Development for Global Health, 18 Kavanagh Street, Southbank, Victoria 3006, Australia.

Christine M Halleux (CM)

UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, 1211 Geneva 27, Switzerland.

Adrian Hopkins (A)

Neglected and Disabling Diseases of Poverty Consultant, Gravesend, Kent DA11 OSL, UK.

Annette C Kuesel (AC)

UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, 1211 Geneva 27, Switzerland.

Sally Kinrade (S)

Medicines Development for Global Health, 18 Kavanagh Street, Southbank, Victoria 3006, Australia.

Maria-Gloria Basáñez (MG)

London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, UK.
MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, UK.
ORCID: 0000-0001-5031-3361

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Can mass drug administration of moxidectin...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Infections de la peau › Dermatoses parasitaires › Onchocercose › Can mass drug administration of moxidectin...
questionsmedicales.fr › Composés chimiques organiques › Lactones › Ivermectine › Can mass drug administration of moxidectin...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Contrôle des maladies transmissibles › Administration massive de médicament › Can mass drug administration of moxidectin...
questionsmedicales.fr › Régions géographiques › Afrique › Can mass drug administration of moxidectin...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladies négligées › Can mass drug administration of moxidectin...